AstraZeneca launches its new diabetes drug Onglyza
The world’s seventh-largest pharma company, AstraZeneca Pharma and biopharmaceutical firm Bristol-Myers Squibb have launched their 9-month-old diabetes drug Onglyza in India – the biggest market for the drug.